Latest news
Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026 - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTAprea Plans APR-1051 Cancer Combinations as Trial Sites Rise 3 to 10 - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMT